The Cooper Companies Announces Third Quarter 2016 Results
Sep 01, 2016 20:15 pm UTC| Business
PLEASANTON, Calif., Sept. 01, 2016 -- The Cooper Companies, Inc. (NYSE:COO) today announced financial results for the fiscal third quarter ended July 31, 2016. Revenue increased 11% year-over-year to $514.7 million....
Globus Medical Completes Acquisition of Alphatec’s International Business
Sep 01, 2016 20:15 pm UTC| Business
AUDUBON, Pa., Sept. 01, 2016 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has successfully completed the previously announced acquisition of the...
Sep 01, 2016 20:15 pm UTC| Business
PLEASANTON, Calif., Sept. 01, 2016 -- The Cooper Companies, Inc. (NYSE:COO) today announced that Gregory W. Matz, senior vice president, chief financial officer and chief risk officer, plans to retire from the company...
Sep 01, 2016 20:15 pm UTC| Business
CHELMSFORD, Mass., Sept. 01, 2016 -- Mercury Systems, Inc. (NASDAQ:MRCY) (www.mrcy.com), announced that it will participate in the Gabelli and Company 22nd Annual Aerospace Satellite Connectivity Conference to be held...
West Positioned as a Leader in Gartner UCaaS Magic Quadrant for Fifth Consecutive Year
Sep 01, 2016 20:14 pm UTC| Business
CHICAGO, Sept. 01, 2016 -- West Corporation, a leading provider of communication services, is proud to announce today that Gartner, Inc. has positioned the Company in the Leaders Quadrant of its annual “Magic Quadrant...
Navios Maritime Holdings Inc. Regains Compliance with NYSE Continued Listing Requirements
Sep 01, 2016 20:06 pm UTC| Business
MONACO, Sept. 01, 2016 -- Navios Maritime Holdings Inc.(“Navios Holdings” or the “Company”)(NYSE:NM) announced today that, based upon a notice received on September 1, 2016 from the New York Stock Exchange, Inc....
Sep 01, 2016 20:05 pm UTC| Business
MOUNTAIN VIEW, Calif., Sept. 01, 2016 -- ChemoCentryx, Inc., (Nasdaq:CCXI) today announced initial 12 week overall response rate (ORR) results from an ongoing open label, single arm Phase Ib clinical trial with CCX872...